Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial

The present study (KGOG 3030) aimed to evaluate the safety of modulated electro-hyperthermia (mEHT) therapy with weekly administration of paclitaxel or cisplatin in female patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma. A total of 12 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kidong, Kim, Jae-Hoon, Kim, Seung Cheol, Kim, Yong Beom, Nam, Byung-Ho, No, Jae Hong, Cho, Hanbyoul, Ju, Woong, Suh, Dong Hoon, Kim, Yun Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145814/
https://www.ncbi.nlm.nih.gov/pubmed/34055086
http://dx.doi.org/10.3892/etm.2021.10219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145814/
https://www.ncbi.nlm.nih.gov/pubmed/34055086
http://dx.doi.org/10.3892/etm.2021.10219

Ejemplares similares